SeraCare Life Sciences unsecured creditors committee appointed

By Caroline Salls

Pittsburgh, April 12 - SeraCare Life Sciences, Inc.'s U.S. Trustee appointed the official committee of unsecured creditors for the company's Chapter 11 case, according to a Tuesday filing with the U.S. Bankruptcy Court for the Southern District of California.

The committee is comprised of Michael P. Murphy of Alix Partners, LLC, San Francisco; Joseph V. Trocato Jr. of Sereux Inc., Ellicott City, Md.; and Howard S. Cherry of DCI Management Group, LLC, Queens Village, N.Y.

SeraCare, an Oceanside, Calif., manufacturer and provider of biological products and services to diagnostic, therapeutic, drug discovery and research organizations, filed for bankruptcy on March 22. Its Chapter 11 case number is 06-00510.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.